LIVANOVA 4000 RESERVOIR

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed with the FDA on 2017-02-17 for LIVANOVA 4000 RESERVOIR manufactured by Sorin Group Usa, Inc..

Event Text Entries

[67704667]
Patient Sequence No: 1, Text Type: N, H10


[67704668] In early (b)(6) 2016, a (b)(6) male, presented for aortic and mitral valve replacement with left atrial appendage device occlusion. The patient was placed on bypass and valves inserted with atrial appendage ligated. There was noted to be some bleeding and the patient was put back on bypass to control the bleeding. There was substantial bleeding coming from behind the heart more on the right hand side. There was also some epicardial surface bleeding several centimeters away from the atrial appendage felt to possibly be due to atriclip applicator. This area was buttressed and made hemostatic. There was still noted to be substantial bleeding coming from the right pulmonary vein. The patient was put back on bypass and the left atriotomy area was pledgeted. Again the patient was weaned off bypass and appeared much more hemostatic. Venous lines were removed when it was felt there was an air free situation. Only the aortic cannula and aortic root vent were in place and there was no real bleeding. At this time the patient had a dip in his blood pressure and it was noticed air frothing through the epicardial surface of the heart and heart distention. Cardiopulmonary resuscitation was started with open chest message. Simultaneously a loud popping noise was heard and it was realized for some undetermined reason the integrated venous reservoir/cardiotomy due to over pressurization of the cardiotomy compartment developed so much pressure it caused it to pop a cap on one of the ports on the top of the reservoir sending blood as high as the ceiling of the operating room. It should be noted that the venous reservoir low-level sensor was on while on bypass as well as an arterial line air bubble detector on while the pump was primed and in use. A new pump and filter were set up and reprimed. A single stage venous cannula was placed in the right atrium and the patient went back on full flow to de-air the heart. It was noted the patient had very low cerebral oximetry after another hour of cardiac arrest. Ultimately an iabp and ecmo were placed and the patient taken to icu at approximately 11:30 where he expired the following morning twelve hours later.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number6339171
MDR Report Key6339171
Date Received2017-02-17
Date of Report2016-10-03
Date of Event2016-09-03
Report Date2016-09-22
Date Reported to FDA2016-09-22
Date Reported to Mfgr2016-09-22
Date Added to Maude2017-02-17
Event Key0
Report Source CodeUser Facility report
Manufacturer LinkN
Number of Patients in Event0
Adverse Event Flag0
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameLIVANOVA
Generic NameRESERVOIR, BLOOD, CARDIOPULMONARY BYPASS
Product CodeDTN
Date Received2017-02-17
Returned To Mfg2016-09-07
Model Number4000 RESERVOIR
Device AvailabilityR
Device AgeDA
Device Eval'ed by Mfgr*
Device Sequence No1
Device Event Key0
ManufacturerSORIN GROUP USA, INC.
Manufacturer Address14401 WEST 65TH WAY ARVADA CO 80004 US 80004


Patients

Patient NumberTreatmentOutcomeDate
10 2017-02-17

© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.